These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 22577909)
1. Elimination of teicoplanin by adsorption to the filter membrane during haemodiafiltration: screening experiments for linezolid, teicoplanin and vancomycin followed by in vitro haemodiafiltration models for teicoplanin. Shiraishi Y; Okajima M; Sai Y; Miyamoto K; Inaba H Anaesth Intensive Care; 2012 May; 40(3):442-9. PubMed ID: 22577909 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection. Yanagihara K; Kaneko Y; Sawai T; Miyazaki Y; Tsukamoto K; Hirakata Y; Tomono K; Kadota J; Tashiro T; Murata I; Kohno S Antimicrob Agents Chemother; 2002 Oct; 46(10):3288-91. PubMed ID: 12234863 [TBL] [Abstract][Full Text] [Related]
3. [Evaluation of vancomycin, teicoplanin, linezolide and tigecycline susceptibilities of nosocomial methicillin-resistant Staphylococcus strains by E-test]. Pelitli TS; Cesur S; Kınıklı S; Irmak H; Demiröz AP; Karakoç E Mikrobiyol Bul; 2011 Oct; 45(4):758-61. PubMed ID: 22090309 [TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil. Kuti JL; Kiffer CR; Mendes CM; Nicolau DP Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672 [TBL] [Abstract][Full Text] [Related]
5. Elimination of linezolid by an in vitro extracorporeal circuit model. Schroeder TH; Hansen M; Stephan M; Hoffmann E; Unertl K; Krueger WA Int J Artif Organs; 2004 Jun; 27(6):473-9. PubMed ID: 15293354 [TBL] [Abstract][Full Text] [Related]
7. Optimization of dosing regimens of vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant Wei X; Zhao M; Xiao X J Chemother; 2021 Dec; 33(8):547-553. PubMed ID: 34080519 [TBL] [Abstract][Full Text] [Related]
8. Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported in diabetic patients. Gonzalez N; Sevillano D; Alou L; Cafini F; Gimenez MJ; Gomez-Lus ML; Prieto J; Aguilar L J Antimicrob Chemother; 2013 Oct; 68(10):2291-5. PubMed ID: 23674766 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus. Docobo-Pérez F; López-Rojas R; Domínguez-Herrera J; Jiménez-Mejias ME; Pichardo C; Ibáñez-Martínez J; Pachón J J Antimicrob Chemother; 2012 Aug; 67(8):1961-7. PubMed ID: 22532466 [TBL] [Abstract][Full Text] [Related]
10. Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics. Samra Z; Ofer O; Shmuely H Isr Med Assoc J; 2005 Mar; 7(3):148-50. PubMed ID: 15792257 [TBL] [Abstract][Full Text] [Related]
11. Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus. Salem AH; Zhanel GG; Ibrahim SA; Noreddin AM Clin Exp Pharmacol Physiol; 2014 Jun; 41(6):437-43. PubMed ID: 24341387 [TBL] [Abstract][Full Text] [Related]
12. Bone tissue and plasma concentrations of linezolid and vancomycin in rabbits with prosthesis-related infection due to MRSA. Swoboda S; Helbig L; Kommerell M; Simank HG; Kees F; Geiss HK; Hoppe-Tichy T; Schröder K Pharmazie; 2009 Jun; 64(6):407-9. PubMed ID: 19618680 [TBL] [Abstract][Full Text] [Related]
13. [The incidence and risk factors for heterogeneous vancomycin intermediate Staphylococcus aureus]. Feng NN; Wang Q; Song YL; He LX; Zhou CM; Xie HM; Li HY Zhonghua Nei Ke Za Zhi; 2013 Apr; 52(4):318-22. PubMed ID: 23925360 [TBL] [Abstract][Full Text] [Related]
15. Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections. Stein GE; Schooley S; Peloquin CA; Missavage A; Havlichek DH J Antimicrob Chemother; 2007 Oct; 60(4):819-23. PubMed ID: 17673476 [TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium. Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of antibiotic susceptibilities and VISA-VRSA rates among MRSA strains isolated from hospitalized patients in intensive care units of hospitals in seven provinces of Turkey]. Cesur S; Irmak H; Simşek H; Cöplü N; Kılıç H; Arslan U; Bayramoğlu G; Baysan BO; Gülay Z; Hoşoğlu S; Berktaş M; Gencer S; Demiröz AP; Esen B; Karabiber N; Aydın F; Yalçın AN Mikrobiyol Bul; 2012 Jul; 46(3):352-8. PubMed ID: 22951647 [TBL] [Abstract][Full Text] [Related]
18. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents]. Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259 [TBL] [Abstract][Full Text] [Related]
19. European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Chastre J; Blasi F; Masterton RG; Rello J; Torres A; Welte T Clin Microbiol Infect; 2014 Apr; 20 Suppl 4():19-36. PubMed ID: 24580739 [TBL] [Abstract][Full Text] [Related]
20. Comparison of in vitro efficacy of linezolid and vancomycin by determining their minimum inhibitory concentrations against methicillin resistant Staphylococcus aureus (MRSA). Kaleem F; Usman J; Khalid A; Hassan A; Omair M J Pak Med Assoc; 2011 Apr; 61(4):356-9. PubMed ID: 21465972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]